Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

286
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
286
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

264
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
264
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

232
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

271
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
271
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

416
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
416
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

243
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
243

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia.

Journal of clinical lipidology·2011
Same author

LDLR promoter variant and exon 14 mutation on the same chromosome are associated with an unusually severe FH phenotype and treatment resistance.

European journal of human genetics : EJHG·2008
Same author

Patient-important outcomes in registered diabetes trials.

JAMA·2008
Same author

Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2007
Same author

Waking up from the DREAM of preventing diabetes with drugs.

BMJ (Clinical research ed.)·2007
Same author

Pioglitazone did not reduce macrovascular complications and increased HF in type 2 diabetes with macrovascular disease.

Evidence-based medicine·2007
Same journal

Managing patients with cardiovascular-kidney-metabolic syndrome: a guideline-driven practical guide for primary care physicians.

Postgraduate medicine·2026
Same journal

CV risk: if you aren't testing ACR, you aren't seeing the full picture.

Postgraduate medicine·2026
Same journal

Anti-TNF-induced vasculitis: analysis of data from the French national pharmacovigilance database.

Postgraduate medicine·2026
Same journal

Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

Postgraduate medicine·2026
Same journal

Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

Postgraduate medicine·2026
Same journal

The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

Postgraduate medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 17, 2026

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
04:09

Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

Published on: September 20, 2024

1000

Thyroid dysfunction in the severely ill and elderly.

William L Isley

    Postgraduate Medicine
    |December 6, 2017
    PubMed
    Summary
    This summary is machine-generated.

    Thyroid dysfunction signs can be misleading in elderly and critically ill patients. Accurate thyroid function tests and interpretation are vital to prevent severe health consequences and guide diagnosis.

    Related Experiment Videos

    Last Updated: Feb 17, 2026

    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
    04:09

    Minimal Invasive Resection of Large Retrosternal Thyroid Goiter

    Published on: September 20, 2024

    1000

    Area of Science:

    • Endocrinology
    • Geriatric Medicine
    • Internal Medicine

    Background:

    • Thyroid dysfunction manifestations can be atypical in elderly and critically ill individuals.
    • Misinterpretation of thyroid function tests can lead to delayed diagnosis and adverse outcomes.
    • Classic signs of thyroid disorders may not be apparent in these vulnerable patient populations.

    Purpose of the Study:

    • To compare classic thyroid disorder symptoms with those observed in elderly and severely ill patients.
    • To provide guidance on the appropriate selection and interpretation of thyroid function tests for these specific groups.
    • To present diagnostic algorithms for thyrotoxicosis and hypothyroidism in challenging clinical scenarios.

    Main Methods:

    • Comparative analysis of clinical signs and symptoms of thyroid dysfunction.
    • Review of thyroid function test interpretation in elderly and critically ill patients.
    • Development of diagnostic algorithms for thyrotoxicosis and hypothyroidism.

    Main Results:

    • Elderly and critically ill patients may present with subtle or atypical signs of thyroid dysfunction.
    • Standard diagnostic criteria may require modification for these patient groups.
    • Algorithms are proposed to aid in the accurate diagnosis of thyroid disorders in these populations.

    Conclusions:

    • Careful selection and interpretation of thyroid function tests are essential for accurate diagnosis in elderly and critically ill patients.
    • Understanding atypical presentations is crucial to avoid misdiagnosis and manage thyroid dysfunction effectively.
    • The proposed algorithms can assist clinicians in diagnosing thyrotoxicosis and hypothyroidism in complex cases.